We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS: No Settlement Yet to Resolve Mylan’s Misclassification of the EpiPen
CMS: No Settlement Yet to Resolve Mylan’s Misclassification of the EpiPen
Mylan has not reached a settlement with the Justice Department to resolve allegations that it misclassified its allergy therapy the EpiPen for a Medicaid program, and as a result, underpaid state rebates, the Centers of Medicare and Medicaid said.